Feb 3, 2020
photo by SGT Christopher Calvert
The Army strives to provide the highest-quality behavioral health care possible to ensure the psychological readiness of every soldier. In support of this effort, the Army asked RAND researchers to identify factors associated with changes in outcomes for soldiers who receive Army behavioral health specialty care.
The Army tracks the percentage of soldiers whose symptoms improve during behavioral health care using treatment outcome measures. Specifically, the Army monitors changes in symptoms for posttraumatic stress disorder (PTSD), depression, and anxiety. Outcome measures include response to treatment (whether symptoms have improved by a specified amount) and remission (whether symptoms have improved and are below a set threshold). Identifying factors associated with improved outcomes can guide the Army's continued quality improvement efforts.
|Response to treatment||35%||22%||14%|
|Response or remission||35%||45%||41%|
NOTE: The definitions of response to treatment and remission used by the Army result in response and remission populations that are exclusive for depression and anxiety but overlap for PTSD.
Knowledge of how soldiers perceive their working relationship with providers may help improve the therapeutic alliance between providers and patients and address patients' concerns about treatment. The Army can encourage providers to routinely assess their therapeutic alliance early in treatment and deliver provider training to help minimize treatment dropout and improve outcomes.
The clinical practice guideline for PTSD from the Veterans Health Administration and Department of Defense cautions against using benzodiazepines as monotherapy or augmentation therapy. RAND results support the Army and Defense Health Agency continuing their efforts to monitor benzodiazepine use and provide feedback to providers.
The Army continues to expand and monitor outcomes for patients who receive behavioral health care. The Behavioral Health Data Portal, an online system that allows for the collection of multiple patient- and clinician-reported measures, is widely used to track PTSD, depression, and anxiety symptoms, but there are opportunities to expand symptom tracking. The Army can support more-frequent collection by providers of patient-reported symptom measures during their behavioral health care. Training on how to routinely use the information from symptom measures to guide treatment decisions and discussions with patients would support increased use of measurement-based care.
In 2018, the Defense Health Agency initiated a program to track benzodiazepine prescribing among providers who treat PTSD and acute stress disorder—the PTS Provider Prescribing Profile. Results are monitored and shared with military treatment facility commanders. The Army's Behavioral Health Service Line is also tracking benzodiazepines and atypical antipsychotic prescriptions for PTSD.